Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Analysis: 5 ways Trump is making things uncertain for medtech

March 3, 2017 By Chris Newmarker

Want a word to sum up 2017? Try “uncertainty.”

Chris Newmarker, Managing Editor

Donald Trump medtech

[Image courtesy of White House]

Wall Street investors remain on a sugar high from the new Trump administration and Republican Congress. The Dow Jones Industrial Average is up hundreds of points since President Donald Trump’s promise to a joint session of Congress on Tuesday that he wanted to massively reduce corporate taxes and “job-crushing regulations.”

For the most part, the medical device industry’s top executives have sounded positive about the situation during earnings calls with analysts. And when Medical Design & Outsourcing and MassDevice readers responded to an online survey about Trump and the Republicans, 42% said they would be good for medtech, versus 33% who thought they would be bad.

Medtech insiders are especially optimistic that the much-hated medical device excise tax will soon be dead for good. They see happy days ahead. “Fully repealing the medical device tax, establishing a more transparent and predictable regulatory process, lowering corporate taxes and properly reimbursing medical technologies would create an environment that allows this proud American industry to thrive,” Mark Leahey, president and CEO of the Medical Device Manufacturers Association, said in a statement after Trump’s address to Congress.

Here is one word, though, that sums up why the device industry should have some pause about the situation: “uncertainty.”

Over my 16 years as a journalist – 10 as a business journalist – I’ve learned that “uncertainty” is a toxic word. It’s the word executives and business owners use when they’re explaining why they aren’t hiring or building a new plant or investing in R&D or taking other risks.

There is a lot of uncertainty in the present political environment. Don’t take my word for it, either. Respected hedge fund manager Seth Klarman – ”The Oracle of Boston” – recently made waves with a private letter to investors, relayed by media outlets including CNBC and The New York Times. Klarman warned that Trump’s unpredictable style and protectionist trade talk create even more risk and uncertainty.

As the ancient Romans liked to say: “Fortune favors the brave.” But it is also smart to identify the unknowns out there, the hazards of the environment in which we are operating.

Here are 5 major uncertainties to keep an eye out for as the year progresses.

Next>>

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

Pages: 1 2 3 4 5 6

About The Author

Avatar photo
Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at [email protected].

Comments

  1. Joe Hage says

    March 5, 2017 at 2:46 am

    Nicely done, Chris.

    • Avatar photoChris Newmarker says

      March 6, 2017 at 9:53 pm

      Thanks, Joe! Appreciate it.

  2. Merlin R Gackle says

    March 7, 2017 at 6:15 pm

    Chris,

    As a veteran of the Insurance, Financial Services and Healthcare DME space for more years than either of you are in age…I(compliment to you both) have seen it all..

    The unfortunate situation with Obamacare, was the political ideaology that was used as the premise to put Obamacare in place….anyone with any smarts or experience, knows, that it was a failure from the beginning. Keep in mind, Obamacare created a larger entitlement society…which are comprised of those uninsured, many of which never wanted insurance….(remember when you were 21 – 30 years old, invincible, never go to a doctor other than for a cold or something, once a year….yet paid premiums either through your employer, for as low as $2,000 per year (40 years ago for, that’s at age 30) and could not justify paying those premiums, UNTIL YOU WERE MARRIED AND HAD A CHILD!!!!)

    For those reasons, TRUMP and his team, were kind and are providing up to $14,000 per year for those who need it, all based upon the need via HSA…..offering tax free accumulation and use for premiums, prescriptions, co-pays and anything medically related including dental needs. Otherwise, we SHOULD repeal entirely….

    No one has to take Maternity, or Birth Control pills or any other benefit as OBAMACARE loaded up everyone on the same standard policy, whether you needed it or not. Now a 28 year old, can have “skinny policy” and pay for what you need, only. WE NOW have a CHOICE on the Individual Market. Secondly, the Individual policies premiums are covered under Section 125 of the IRS code, unlike Obamacare, meaning the premiums are exempt from Federal and State Income taxes.

    Your word”uncertainty” was written on March 3rd, before you have a chance to see the proposed bill, which will certainly have a few changes…Your word “uncertainty” goes away, once the bill is passed and it will pass!

    Lastly, please do not use NY TIMES as your source to interpret anything….It will be slanted to the liberal left, which got this country into the problems we have to correct today…go directly to the Fed.gov site and read it for yourself…. PEOPLE only want the real language….. I read the NYTimes interpretation myself and true their word, they slanted it to show that Obamacare was not so bad after all….Yet, if you lived on the Insurance side of the World, you see the real impact. At least, 11,000,000 to 20,000,000 do not want to pay for insurance, but they’ll take it if you give it to them….but for those who do pay, and do not qualify to get a reimbursement benefit, many do not want to even have the insurance, because their return on investment, is absolutely ridiculous….

    NOW for comments regarding many of my DME clients….it was ridiculous to assess tax on all medical devices….it caused many to change their short term and with many a long-term strategy to re-design their organizations, to reduce costs throughout their organizations. In some cases, seeking opportunities for acquisition strategies, allowing for better corporate tax benefits, especially during the time, given to delay the implementation of the tax to January 2018….THAT WILL BE REPEALED as well, mark my word….as you well know, that tax, would have had to been offset in additional costs to provider, patients and etc. and ultimately a further burden on the Payor and Patient, not a WIN-WIN situation.

    We are going in the right direction….as opposed to have 21 states, that Payors left only one choice for enrollment for those that needed Obamamcare…why? a large majority of the payors are our clients as well…they were losing millions of dollars impacting their bottom line with Obamamcare, with the one size fits all requirement. Smart people know that will never work!

    The real word, should now be”Optimistic,” about the future and allow the free market mandate the competitive rates for all companies to compete, without looking over their shoulder, worried about how they have reserved for a 700 million fine or the like….as an example….

    • Avatar photoChris Newmarker says

      March 8, 2017 at 4:28 pm

      Thanks for sharing your views, Merlin. I agree that there seems to at least be a bit more certainty now that a plan has been released, though passage of the plan is no done deal at all. Here’s the big headscratcher as I see it when it comes to any kind of healthcare/health insurance reform: Someone showing up at a hospital without insurance is my problem. (I’m assuming you have insurance, too, Merlin, so it’s also your problem.) Why? If the person without insurance isn’t able to pay—or worse, goes bankrupt—the cost gets shifted over to insurance-covered people like us. A pure free market solution to the problem would be, “Well, if you don’t have insurance or money, you don’t get healthcare.” But letting someone die on a gurney outside an emergency room door is wrong. So we’re stuck. The government has to step in and do something to make this crazy system work, and it either does it well or poorly.

Related Articles Read More >

An image of the Medical Design & Outsourcing 2026 Medtech Big 100 ranking of the world's largest medical device companies by annual revenue.
The 2026 Medtech Big 100 breaks $500 billion
A photo of an Oura Ring 5.
Oura discloses pay packages for top executives ahead of IPO
An image of the September 2026 Medical Design & Outsourcing magazine featuring the Medtech Big 100 ranking of the world's largest medical device companies.
September 2026 issue: The MDO Medtech Big 100 breaks $500 billion
A photo of Fredrikson attorney Carl Numrich.
What private equity means for medtech OEMs, suppliers and their employees
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe